VLHDDLLEA

VLHDDLLEA is a peptide that can be isolated from the MHC complex HLA-A*0201 molecule. VLHDDLLEA can be recognized by HLA-A*0201-restricted cytotoxic T cells (CTLs) . VLHDDLLEA can be used for research on graft versus host disease (GvHD) [1].

Product Specifications

CAS Number

204931-32-8

UNSPSC

12352209

Target

Others

Type

Peptides

Related Pathways

Others

Applications

Metabolism-protein/nucleotide metabolism

Field of Research

Metabolic Disease

Assay Protocol

https://www.medchemexpress.com/vlhddllea.html

Solubility

10 mM in DMSO

Smiles

OC([C@H](C)NC([C@H](CCC(O)=O)NC([C@H](CC(C)C)NC([C@H](CC(C)C)NC([C@H](CC(O)=O)NC([C@H](CC(O)=O)NC([C@@H](NC([C@H](CC(C)C)NC([C@@H](N)C(C)C)=O)=O)CC1=CN=CN1)=O)=O)=O)=O)=O)=O)=O

Molecular Formula

C45H73N11O16

Molecular Weight

1024.13

References & Citations

[1]den Haan JM, et al. The minor histocompatibility antigen HA-1: a diallelic gene with a single amino acid polymorphism. Science. 1998 Feb 13;279 (5353) :1054-7. d